Product Information
CINACALCET HCL 30 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.4030 per EA under NDC 47335037983. Its NADAC has been published 334 times since Oct 2, 2019.
FDA first approved this application on Oct 11, 2018.
Strength
30 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335037983
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
CINACALCET HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207008FDA Approved
10/11/2018
On Market Since
5/15/2019
Pharmacological Classes
Price Statistics
The NADAC for CINACALCET HCL 30 MG TABLET has been published 334 times since Oct 2, 2019, and over the history we have for it it has declined 97.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4030 per EA |
|---|---|
| All-time high | $17.2465 (Oct 16, 2019) |
| All-time low | $0.2542 (Nov 20, 2024) |
| 52-week high | $0.4156 |
| 52-week low | $0.3573 |
| Median price | $0.4074 |
| Average price | $2.7758 |
| Largest weekly change | -58.1% (Sep 21, 2022) |
| Weeks tracked | 334 |
| Tracking since | Oct 2, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+12.8%
3Y
+31.7%
5Y
-62.7%
All
-97.7%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cinacalcet market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium-sensing Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CINACALCET HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CINACALCET HCL 30 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.4030 per EA (NDC 47335037983), effective Feb 18, 2026.
How has the price of CINACALCET HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for CINACALCET HCL 30 MG TABLET has declined 97.7%. It has been tracked across 334 weekly CMS publications since Oct 2, 2019.
What are the highest and lowest recorded NADAC prices for CINACALCET HCL 30 MG TABLET?
Since Oct 2, 2019, the NADAC for CINACALCET HCL 30 MG TABLET has ranged from a low of $0.2542 (Nov 20, 2024) to a high of $17.2465 (Oct 16, 2019), with a median of $0.4074 per EA.
Are there cheaper alternatives to CINACALCET HCL 30 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CINACALCET HCL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CINACALCET HCL 30 MG TABLET?
CINACALCET HCL 30 MG TABLET (NDC 47335037983) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.